CDMRP: the disease funding most biotech founders never search
Congress directs money to specific diseases through the Department of Defense. It is a different portal, different vocabulary, and the same companies are eligible — most just never look.
Ask a founder where non-dilutive money comes from and you will hear NIH. Ask a second question and you usually get silence.
The Congressionally Directed Medical Research Programs sit inside the Department of Defense and fund research across a wide range of diseases — cancers, neurological conditions, rare disease, and more, with the specific programmes set by Congress each cycle. Many of them are open to small businesses.
Almost none of the founders we talk to have searched it.
Why it gets missed
It is a different portal with different vocabulary. People search where they already look. Award mechanisms carry names that do not map onto NIH's, so even a founder who stumbles onto it often cannot tell which awards they qualify for.
It sits under Defense, which reads as irrelevant. A preclinical oncology company does not intuitively search the DoD. The programme names, not the parent department, are what matter.
The programme list changes. Because it is congressionally directed, which diseases are funded and at what level moves between cycles. Last year's list is not this year's, so one-off research goes stale quickly.
What makes it worth the effort
The award structures differ from NIH's, and some are explicitly designed for work that is early, translational, or high-risk in ways that do not compete well in a standard study section. For a company whose science is genuinely novel but thin on preliminary data, that difference can matter more than the dollar amount.
It is also, bluntly, less crowded. Not easy — less crowded. Competing against a smaller field of applicants who knew to look is a materially different situation than competing against everyone who searched the obvious place.
How to approach it
- Start from the disease, not the agency. Find the programme that funds your
indication this cycle, then read what award types it offers.
- Check the eligibility line for each award type separately. Within a single
programme, some awards are open to companies and others are restricted to academic investigators or require particular career stages.
- Watch the calendar. Pre-applications are common and are often weeks before
the full submission, with the full application invited only after.
The broader point is not about one agency. Ten-plus federal bodies fund life-science work, they publish on different schedules, and no founder has time to monitor all of them by hand. The money you never hear about is not the money you were rejected for — it is the money that closed while you were looking somewhere else.
SixthGrant scans them as one map, in your vocabulary, and tells you which awards you are actually eligible for.
Stop finding out too late.
SixthGrant reads every federal solicitation daily, checks each one against your company, and tells you what changed.
See what it costs →